The Ehlers-Danlos Society Receives $6.7 Million from the Mike and Sofia Segal Foundation to Advance Cutting-Edge Research for Ehlers-Danlos Syndrome
Summary
It will fuel innovative studies into the underlying mechanisms of EDS and HSD, identify novel therapeutic strategies, and enhance quality of life for individuals affected by these complex disorders.The Ehlers-Danlos syndromes are a group of inherited disorders impacting the bodys connective tissues. Among the many complications of EDS, this leads to skin fragility, bruising, and poor healing; joint instability with subluxations, dislocations, injury and pain; other abnormalities of joint structure; abnormalities, of the eyes; dental issues; and, in some of the rarer types, life-threatening complications such as heart valve disease, rupture of organs (e.g., bowel), aneurysm formation, and rupture of major blood vessels. "This gift to EDS reflects our steadfast commitment to support cutting-edge treatments for, and educate the public about, a range of rare diseases," said Mike Segal. And it intends to make additional gifts in the near future.The partnership between the Ehlers-Danlos Society and the Foundation marks a significant leap forward in the quest for breakthroughs in EDS and HSD research. It will leverage the expertise and dedication of the Ehlers-Danlos Society, a global leader in advocating for those affected by these complex conditions, and the Foundations unwavering commitment to driving advancements in healthcare.